CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Pantoprazole",CYP2C19,"Minor – result should be considered as may affect medicationresponse"
"Venlafaxine",CYP2D6,Usual prescribing considerations apply
MEDICATIONS THAT DO NOT HAVE PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,,
"infliximab (Remicade), indapamide, valsartan, insulin / insulin (Humalog), metformin (Metformin), hydroxyzinehydrochloride (Hydroxyzine Hydrochloride Injection)",,
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9","Significantly increasedacenocoumarol sensitivity",DPWG
"",Warfarin,"VKORC1CYP2C9","Significantly increased warfarinsensitivity",FDA1
Antiplatelet drugs,Clopidogrel,CYP2C19,Reduced / inadequate response,CPIC2
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Antidepressants -other",Moclobemide,CYP2C19,Adverse effects,-
"Antidepressants -SSRIs",Citalopram,CYP2C19,Adverse effects,CPIC3
"",Escitalopram,CYP2C19,Adverse effects,CPIC3
"",Sertraline,CYP2C19,Adverse effects,CPIC3
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Altered response,CPIC4
"",Clomipramine,"CYP2D6CYP2C19",Altered response,CPIC4
"",Doxepin,"CYP2D6CYP2C19",Altered response,CPIC4
"",Imipramine,"CYP2D6CYP2C19",Altered response,CPIC4
Antidiabetics,Gliclazide,"CYP2C9CYP2C19","Increased therapeutic and/oradverse effects",-
Antifungals - Azoles,Voriconazole,CYP2C19,"Increased therapeutic and/oradverse effects",CPIC5
Benzodiazepines,Clobazam,CYP2C19,Adverse effects,-
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Diazepam,CYP2C19,Adverse effects,-
Miscellaneous,Cyclophosphamide,CYP2C19,Reduced / inadequate response,-
"",Naltrexone,OPRM1,"Associated with reducedresponse to naltrexone",
"",Proguanil,CYP2C19,Reduced / inadequate response,-
Opioid Analgesics,Morphine,OPRM1,"Associated with increasedtherapeutic and/or adverseeffects to morphine",-
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",FDA6
Esomeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-,
Lansoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-,
Omeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-,
Pantoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-,
Rabeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,"No altered effect predicted bygenotype",-
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"No altered effect predicted bygenotype",-
"",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
Antiarrhythmics,Flecainide,CYP2D6,"No altered effect predicted bygenotype",-
"",Propafenone,CYP2D6,"No altered effect predicted bygenotype",-
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,"No altered effect predicted bygenotype",-
"",Fesoterodine,CYP2D6,"No altered effect predicted bygenotype",-
"",Tolterodine,CYP2D6,"No altered effect predicted bygenotype",-
Anticholinesterases,Donepezil,CYP2D6,"No altered effect predicted bygenotype",-
"",Galantamine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
"",Vortioxetine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
Venlafaxine,CYP2D6,"No altered effect predicted bygenotype",DPWG7,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Antidepressants -SSRIs",Fluoxetine,"CYP2D6CYP2C9","No altered effect predicted bygenotype",-
"",Fluvoxamine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",CPIC3
"",Paroxetine,CYP2D6,"No altered effect predicted bygenotype",CPIC3
"Antidepressants -tricyclicantidepressants",Desipramine,CYP2D6,"No altered effect predicted bygenotype",CPIC4
"",Nortriptyline,CYP2D6,"No altered effect predicted bygenotype",CPIC4
Antidiabetics,Glimepiride,CYP2C9,"No altered effect predicted bygenotype",-
"",Glyburide,CYP2C9,"No altered effect predicted bygenotype",-
Antiemetics,Metoclopramide,CYP2D6,"No altered effect predicted bygenotype",-
"",Ondansetron,CYP2D6,"No altered effect predicted bygenotype",CPIC8
Antiepileptics,Phenytoin,CYP2C9,"No altered effect predicted bygenotype",CPIC9
Antihistamines,Chlorpheniramine,CYP2D6,"No altered effect predicted bygenotype",-
"",Dexchlorpheniramine,CYP2D6,"No altered effect predicted bygenotype",-
"",Promethazine,CYP2D6,"No altered effect predicted bygenotype",-
Antipsychotics,Aripiprazole,CYP2D6,"No altered effect predicted bygenotype",-
"",Brexpiprazole,CYP2D6,"No altered effect predicted bygenotype",-
"",Chlorpromazine,CYP2D6,"No altered effect predicted bygenotype",-
"",Clozapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Haloperidol,CYP2D6,"No altered effect predicted bygenotype",-
"",Olanzapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Pimozide,CYP2D6,"No altered effect predicted bygenotype",
"",Quetiapine,CYP3A4,"No altered effect predicted bygenotype",-
"",Risperidone,CYP2D6,"No altered effect predicted bygenotype",-
"",Zuclopenthixol,CYP2D6,"No altered effect predicted bygenotype",-
Antitussives,Dextromethorphan,CYP2D6,"No altered effect predicted bygenotype",-
Beta blockers,Carvedilol,CYP2D6,"No altered effect predicted bygenotype",-
Metoprolol,CYP2D6,"No altered effect predicted bygenotype",-,
Nebivolol,CYP2D6,"No altered effect predicted bygenotype",-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Propranolol,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC10
"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
Hypnotics,Melatonin,CYP1A2,"No altered effect predicted bygenotype",-
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,"No altered effect predicted bygenotype",CPIC11
Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
"",Eliglustat,CYP2D6,"No altered effect predicted bygenotype",TGA12
Neurological drugs,Tetrabenazine,CYP2D6,"No altered effect predicted bygenotype",FDA13
NSAIDs,Celecoxib,CYP2C9,"No altered effect predicted bygenotype",-
"",Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-
"",Flurbiprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Ibuprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
"",Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
"",Meloxicam,CYP2C9,"No altered effect predicted bygenotype",-
"",Piroxicam,CYP2C9,"No altered effect predicted bygenotype",-
Opioid Analgesics,Codeine,"CYP2D6OPRM1","Associated with increasedsensitivity to codeine",CPIC14
"",Hydrocodone,CYP2D6,"No altered effect predicted bygenotype",
"",Oxycodone,CYP2D6,"No altered effect predicted bygenotype",-
"",Tramadol,CYP2D6,"No altered effect predicted bygenotype",-
Psychostimulants,Dextroamphetamine,CYP2D6,"No altered effect predicted bygenotype",-
"",Lisdexamfetamine,CYP2D6,"No altered effect predicted bygenotype",-
Statins,Atorvastatin,"SLCO1B1CYP3A4","No altered effect predicted bygenotype",-
Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-,
Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Simvastatin,"SLCO1B1CYP3A4","No altered effect predicted bygenotype",CPIC15,
